Forum Home > GMAT > Quantitative > Problem Solving (PS)
Events & Promotions
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Jul 2710:00 AM PDT
-11:00 AM PDT
Are you struggling with the GMAT verbal section? Do tricky questions and lengthy passages overwhelm you? Don't worry—I've got you covered! In this video, I'll provide a detailed, actionable plan to help you significantly boost your verbal score.
Jul 2508:00 AM EDT
-11:59 PM EDT
More and more TTP students are earning impressive scores on the GMAT. Now is the perfect time to join the many GMAT students who made the switch to TTP and surpassed their wildest expectations on test day.- Jul 28
10:00 AM PDT
-11:00 AM PDT
We will learn how to guess an answer choice better on the GMAT. If you are running out of time and want to guess on a few questions, these effective techniques will help you in making a smart guess. 
Jul 2811:00 AM IST
-01:00 PM IST
Attend this free GMAT Algebra Webinar and learn how to master the most challenging Inequalities and Absolute Value problems with ease.- Jul 31
05:55 AM PDT
-12:30 PM PDT
MBA Application Walkthrough and Essay Review. You will have a chance to hear from experts covering the Top 15 MBA programs, covering details of the application and essays. 
Jul 3110:00 AM EDT
-11:59 PM PDT
Save 20% on Target Test Prep and Score in the 100th Percentile in GMAT Verbal! Our course uses techniques such as topical study and spaced repetition to maximize knowledge retention and make studying simple and fun.
Re: The pharmaceutical industry argues that because new drugs will not be
[#permalink]
01 Apr 2021, 06:45
01 Apr 2021, 06:45
VeritasKarishma
Dear Karishma,
could you enlighten regarding the answer B.
What if other industries, which develop new product despite the high development cost, also spend 10 year for development, and thus still have 10 year for sales? If we do not have ample information concerning the other industries, how can we infer that option D is right contender?
Dear Karishma,
could you enlighten regarding the answer B.
What if other industries, which develop new product despite the high development cost, also spend 10 year for development, and thus still have 10 year for sales? If we do not have ample information concerning the other industries, how can we infer that option D is right contender?
Re: The pharmaceutical industry argues that because new drugs will not be
[#permalink]
01 Apr 2021, 07:19
01 Apr 2021, 07:19
BLTN wrote:
VeritasKarishma
Dear Karishma,
could you enlighten regarding the answer B.
What if other industries, which develop new product despite the high development cost, also spend 10 year for development, and thus still have 10 year for sales? If we do not have ample information concerning the other industries, how can we infer that option D is right contender?
Dear Karishma,
could you enlighten regarding the answer B.
What if other industries, which develop new product despite the high development cost, also spend 10 year for development, and thus still have 10 year for sales? If we do not have ample information concerning the other industries, how can we infer that option D is right contender?
Quote:
The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary.
Which of the following, if true, most strongly supports the pharmaceutical industry’s argument against the challenge made above?
(B) Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete.
(D) An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug.
Which of the following, if true, most strongly supports the pharmaceutical industry’s argument against the challenge made above?
(B) Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete.
(D) An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug.
I tried this question after more than a month and this time I got it correct. I would like to share my thoughts on accepting B and rejecting D.
If you notice the highlighted words, You would find that you request to extend the period , What happened recently? How this extension can help in actual?
In B ,I could find the reason that now it takes as long as 10 years, so pharmaceutical industry time might be less than what it used to before.
( pharmaceutical industry would raise concern if they lose revenue due to some process that takes longer than before . if process were efficient then they would not raise request of extension)
But IN D, I didn;t find any reason to extend now from 20 years. if pharmaceutical industry were losing business before, how even this solution can work? If people want to buy fake medicines then how can extension would help? Because I couldn't find reason of extension that's why I rejected this option.
I hope it helps. BLTN
carouselambra : How is my reasoning for B and D.
Thanks
Re: The pharmaceutical industry argues that because new drugs will not be
[#permalink]
01 Apr 2021, 23:27
01 Apr 2021, 23:27
1
Kudos
Expert Reply
BLTN wrote:
VeritasKarishma
Dear Karishma,
could you enlighten regarding the answer B.
What if other industries, which develop new product despite the high development cost, also spend 10 year for development, and thus still have 10 year for sales? If we do not have ample information concerning the other industries, how can we infer that option D is right contender?
Dear Karishma,
could you enlighten regarding the answer B.
What if other industries, which develop new product despite the high development cost, also spend 10 year for development, and thus still have 10 year for sales? If we do not have ample information concerning the other industries, how can we infer that option D is right contender?
Option (B) is supporting the pharma industry's cause. That is what we need to look for. If same is the case for other industries too, the author will need to come up with that information and extend the argument. As of now, in our current argument, we are not given this. We just need to pick the option that helps the pharma industry's case as per the current argument. How additional data may impact this option, we don't need to worry.
